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Abstract 
Background 
The Internet is becoming more commonly used as a tool for disease surveillance. Similarly to 
other surveillance systems and to studies using online data collection, Internet-based 
surveillance will have biases in participation, affecting the generalizability of the results. 
Here we quantify the participation biases of Influenzanet, an ongoing European-wide network 
of Internet-based participatory surveillance systems for influenza-like-illness. 
Methods 
In 2011/2012 Influenzanet launched a standardized common framework for data collection 
applied to seven European countries. Influenzanet participants were compared to the general 
population of the participating countries to assess the representativeness of the sample in 
terms of a set of demographic, geographic, socio-economic and health indicators. 
Results 
More than 30,000 European residents registered to the system in the 2011/2012 season, and a 
subset of 25,481 participants were selected for this study. All age classes (10 years brackets) 
were represented in the cohort, including under 10 and over 70 years old. The Influenzanet 
population was not representative of the general population in terms of age distribution, 
underrepresenting the youngest and oldest age classes. The gender imbalance differed 
between countries. A counterbalance between gender-specific information-seeking behavior 
(more prominent in women) and Internet usage (with higher rates in male populations) may 
be at the origin of this difference. Once adjusted by demographic indicators, a similar 
propensity to commute was observed for each country, and the same top three transportation 
modes were used for six countries out of seven. Smokers were underrepresented in the 
majority of countries, as were individuals with diabetes; the representativeness of asthma 
prevalence and vaccination coverage for 65+ individuals in two successive seasons 
(2010/2011 and 2011/2012) varied between countries. 
Conclusions 
Existing demographic and national datasets allowed the quantification of the participation 
biases of a large cohort for influenza-like-illness surveillance in the general population. 
Significant differences were found between Influenzanet participants and the general 
population. The quantified biases need to be taken into account in the analysis of Influenzanet 
epidemiological studies and provide indications on populations groups that should be targeted 
in recruitment efforts. 
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Background 
Monitoring influenza epidemics through surveillance is essential for providing public health 
recommendations in areas including vaccines, antiviral susceptibility and risk assessment [1]. 
At the national level, general practice (GP) sentinel surveillance schemes collate information 
on influenza-like-illness (ILI) of visited patients and, in some cases, collect respiratory 
specimens. 
Alongside these well-established schemes, novel opportunities for surveillance in the general 
population have been opened by the advent of new technologies that promote the 
participation of individuals through the Internet, creating information in a bottom-up fashion 
outside of established practices and routines [2]. A participatory system was introduced in 
The Netherlands in 2003 for ILI surveillance in the general population by means of an online 
platform [3], offering a source of disease information generated directly by the users. The 
system has expanded to other European countries establishing an international participatory 
surveillance network (Influenzanet). The network has a standardized common framework for 
data collection [4,5], thus overcoming possible fragmentations in case definitions and 
systems design of GP surveillance across countries. 
To be of value in providing information to guide health policy, the collected data need to be 
related to the epidemic situation in the underlying population. In agreement with 
recommendations for GP surveillance networks [6], here we evaluate the quality of the 
collected data by assessing the representativeness of the participating (i.e. monitored) 
individuals in the Influenzanet cohort. The advantage with respect to other surveillance 
schemes (e.g. GPs or other digital approaches of unsupervised nature, such as web search 
records [7,8], online news [9,10], or tweets [11]) is the ability to ask users about themselves– 
including geographic, demographic, mobility, socio-economic and health indicator questions; 
this information can be compared with national statistics. The aim is to identify possible 
biases to be taken into account for epidemiological analyses. Furthermore, the comparison of 
representativeness results across countries may guide informed strategies to improve 
coverage and participation of underrepresented population groups in the following seasons. 
Methods 
Study design 
Influenzanet is a European multicenter network [4] for ILI surveillance in the general 
population through online systems. Starting the 2011/2012 season, Influenzanet was launched 
with a uniform and standardized data collection approach in seven European countries (The 
Netherlands [3,12], Belgium (Flemish region only) [12,13], Portugal [14,15], Italy [16], 
United Kingdom (UK) [17,18], Sweden [19], France [20,21]), leveraging on pre-existing 
participatory surveillance activities [5]. In each country, this surveillance system is 
coordinated by local research and public health teams and Institutions (see the Additional file 
1 for further details). 
Focusing on the 2011/2012 Influenzanet season, we analyzed seven national data collection 
campaigns that started in November 2011 and ended in April or May 2012, with few 
exceptions (Additional file 1: Table S1). Differences were mainly related to country-specific 
practical issues (e.g. launch following the Ethical approval in France, or to coincide with 
public health events or communications for the upcoming influenza season). 
Influenzanet consists of a website with centralized information on the network and results 
from each participating country [4] that links to the national online platforms, each in the 
national language and with a country-specific name, but characterized by a common website 
template. National platforms are used to register participants, to give them access to their 
account where they can upload information, and to publish summary surveillance results in 
real time. 
Participation is voluntary and anonymous, and open to all residents of the countries 
composing the multi-center network (in France, overseas territories and French individuals 
under 18 years old were not considered, the latter due to regulatory constraints applied to the 
first season only). Recruitment occurred with the help of press releases of the supporting 
institutions, media communications, specific advertising events (e.g. schools activities or 
science fairs), and through emails and word of mouth. More details can be found on the 
national platforms [12,14,16,18-20]. In some countries, weekly reports on Influenzanet 
results were also published within the official national surveillance bulletins [22,23]. 
For sensitivity analysis, we also performed the same analyses on the two following influenza 
seasons, 2012/2013 and 2013/2014. 
Privacy and ethical approval 
This study was conducted in agreement with country-specific regulations on privacy and data 
collection and treatment. Informed consent was obtained from all participants enabling the 
collection, storage, and treatment of data, and their publication in anonymized, processed, 
and aggregated forms for scientific purposes. In addition, approvals by Ethical Review 
Boards or Committees were obtained, where needed according to country-specific 
regulations. In The United Kingdom, the Flusurvey study was approved by the London 
School of Hygiene and Tropical Medicine Ethics Committee (Application number 5530). In 
Sweden, the Influensakoll study was approved by the Stockholm Regional Ethical Review 
Board (Dnr. 2011/387-31/4). In France, the Grippenet.fr study was approved by the Comité 
consultatif sur le traitement de l’information en matière de recherche (CCTIRS, Advisory 
committee on information processing for research, authorization 11.565) and by the 
Commission Nationale de l’Informatique et des Libertés (CNIL, French Data Protection 
Authority, authorization DR-2012-024). In Portugal, the Gripenet project was approved by 
the National Data Protection Committee and also by the Ethics Committee of the Instituto 
Gulbenkian de Ciência. 
Data collection 
To join the network, users registered on their national platform. Upon registration, the user 
was asked to complete an intake survey, covering demographic factors (age, gender), 
geographic factors (location of home and work/school expressed at the municipality or 
zipcode level), socio-economic factors (household size and composition, occupation, 
educational level, daily transportation means), and health-related factors (including 
vaccination status against influenza in the 2011/2012 and previous season, diet, pregnancy 
status, smoking habits, and medical conditions associated with higher risk of influenza 
complications). The intake survey was standardized and translated whilst preserving the same 
type and content of questions and possible answers, as well as the same order of questions 
within the survey, and accounting for the differences related to specific national standards 
(e.g. schooling structure and associated age/degrees). A few additional questions were added 
by some platforms due to differences in national public health regulations or to gather 
additional profiling information. The survey is available in English in the Additional file 2. 
A multi-user account was also available to allow the registration of multiple individuals 
through a single account. The aim was to facilitate group participation (e.g. family members) 
and also to access groups who otherwise would be unlikely to participate (e.g. children or 
elderly not familiar with the Internet). 
All users were asked to fill in the intake survey at least once, prior to participating to the 
surveillance. The intake survey could be updated throughout the season (e.g. because of 
change of residence, vaccination or pregnancy status). When multiple intake surveys were 
available for a user, in the present study we used the most recently completed one. In the 
sensitivity analysis, we quantified the type of changes made in the updated surveys and tested 
the effect of discarding the updates. 
Influenza-like-illness surveillance data were obtained through weekly symptoms surveys. No 
data from the weekly symptoms surveys was considered in this study; however the number 
and frequency of reporting by each user was used to evaluate the user’s active participation in 
the surveillance network. 
A schematic representation of the Influenzanet data collection is shown in Figure 1. 
Figure 1 Flow chart of Influenzanet data collection. The schematic diagram illustrates the 
processes of registration, account confirmation, and data collection through intake and 
weekly symptoms surveys. 
Inclusion criteria 
All intake questionnaires filled in between the start date and the closure date of the data 
collection campaign for the 2011/2012 season were considered in the analysis. Following 
previous work [13,15,21,24], we included in our sample only active participants (defined as 
those who completed an intake survey and at least three weekly symptoms surveys, to avoid 
results being skewed by sporadic participation). We will refer to these as Influenzanet active 
participants or Influenzanet participants. We tested different inclusion criteria and performed 
a sensitivity analysis with the stricter inclusion criterion that each participant filled in at least 
one weekly symptoms survey per calendar month. 
Users who did not specify age/gender details were additionally removed from the sample, as 
demographic biases could not be assessed nor accounted for in a sample weighting procedure. 
Census and health data sources 
We collected national data from a number of socio-demographic datasets and health datasets 
for all participating countries. In absence of data for the years 2011 or 2012, we relied on the 
most recent available sources. 
Demographic and geographic data were taken from the European Commission portal for 
European Statistics [25] and from national institutes of statistics. Georeferenced census data 
were obtained from the Nomenclature of Territorial Units for Statistics (NUTS), a standard 
geocode for referencing the subdivisions of countries for statistical purposes, developed by 
the European Union [26]. We considered the NUTS2 level, corresponding to basic regions 
for the application of regional policies. 
All other socio-economic data were taken from European Statistics and national sources: 
household size and composition [27,28]; education data [29-31]; employment data [32]; 
transport habits [33]; vaccination coverage data [34-41]; diabetes prevalence data [42-48]; 
asthma prevalence data [44,49-53]; smoking prevalence data [54]; body mass index (BMI) 
data for France [55]. 
Commuting data was collected for all countries from national institutes of statistics or 
departments of transportation [56]. Namely, we used data on the number of daily commuters 
from location of origin to location of destination. 
Data analysis 
The representativeness of the Influenzanet population was assessed through the comparison 
of its characteristics with those of the general population for each country. We used χ2-test for 
non-continuous sociodemographic variables, and Student’s t-test for mean comparisons. All 
comparisons used 2-tailed tests and a 5% cutoff point. To assess whether differences in 
participation rates between countries were associated with differences in Internet coverage 
(access and usage [57]), a test for association between paired samples was considered, using 
Pearson’s product moment correlation coefficient, Kendall’s τ or Spearman’s ρ. Statistical 
analyses were performed using the R software version 2.13.2 (R Development Core Team, R 
Foundation for Statistical Computing, Vienna, Austria, http://www.r-project.org). 
Age data were analyzed in 10-years age categories up to an aggregated 70+ class. For France 
we had a category of 18-19 years old individuals, because of the absence of younger 
participants during the data collection campaign here analyzed. We additionally split the 60-
69 class into two categories, 60-64 and 65-69 years of age, to account for the age definition 
(65+) of individuals at risk for developing flu-related complications. 
Georeferenced data from Influenzanet were mapped from zip codes or municipality 
resolution to NUTS2 level for comparison with national data. Apart from the geographic and 
demographic characteristics, all other variables were adjusted by age (10-years categories) 
and gender. 
The household composition question offered a list of age groups to be ticked, next to open 
fields where to indicate the number of individuals in the household for each selected age 
group (Intake Q6 in Additional file 2). When no number was indicated, we assumed that one 
individual belonged to the selected age group. 
Commuting data, extracted from countries’ census and from Influenzanet population, were 
mapped to NUTS2 level. Data were analyzed in terms of networks of nodes and links [58,59], 
with nodes representing the NUTS2 regions and directed links the commuting movement 
between regions. A weight wOD was also assigned to each link from origin O to destination D 
to indicate the number of commuters on that connection. Adjusted analyses by geographic 
distribution of the population were performed (Additional file 1). We assessed whether the 
Influenzanet links reproduce the backbone of the census commuting network defined by 
extracting for each country a portion of census network of the same size of the Influenzanet 
commuting network containing the highest traffic links. An alternative definition of backbone 
was tested for sensitivity analysis using the disparity filter algorithm [60] (Additional file 1). 
We quantified the overlap between the Influenzanet commuting network and the census one 
through the Jaccard index, measuring the ratio between the number of common links in the 
two networks and the total number of links. The index is defined in the range [0,1] where 0 
indicates that no common link is observed and 1 indicates that the two sets are identical. We 
calculated the probability of occurrence of the directed links in the Influenzanet commuting 
(POD), given the probability of commuting from O to D computed from national census data 
and the sample of the Influenzanet participants in region O. Details on the computation are 
reported in the Additional file 1. 
Results 
Descriptive analysis 
A total of 31,674 residents in 7 European countries participated in the 2011/2012 season 
(Table 1), during a time period of at least 14 weeks. Based on the inclusion criteria, we 
analyzed a set of 25,481 active participants, representing 80% of the total. Active 
participation was observed for the majority of individuals in each national sample (from 55% 
in Italy to 90% in Belgium), with large variations in the active participation rate per country, 
ranging from 2.1 per 100,000 in Italy to 76.2 per 100,000 in The Netherlands. When 
compared to Internet access and usage statistics for 2011 (Table 2), we found a positive 
correlation with the indicators representing access in households (generic Internet access and 
Internet broadband access) and frequent Internet usage (at least once a week), and a negative 
correlation with the percentage of individuals who never used the Internet, although all 
statistical tests were non-significant. 
Table 1 Participation to Influenzanet in the 2011/2012 season 
Influenzanet 
country 
no. registered 
individuals 
no. active** 
participants 
% active in 
sample 
no. active in country 
(per 100,000) 
BE 4,362 3,915 90% 56.7 
FR* 3,936 3,044 77% 6.2 
IT 2,283 1,266 55% 2.1 
NL 14,479 12,699 88% 76.2 
PT 1,410 1,075 76% 10.2 
SE* 2,657 1,676 63% 17.8 
UK 2,547 1,806 71% 2.9 
Influenzanet 31,674 25,481 80% 8.0 
* first season. 
** an active participant is defined as having filled at least three weekly symptoms surveys; it 
is also referred in the article simply as participant (see main text). 
  
Table 2 Participation rates to Influenzanet per country compared to 2011 Internet access and usage statistics 
country no. Influenzanet 
participants per 
100,000 (rank) 
% individuals using the 
internet at least once a  
week (rank) 
% internet access in 
households (rank) 
% broadband internet 
connections in households 
(rank) 
% individuals who never 
used the Internet (rank) 
NL 76.2 (1) 90% (2) 94% (1) 83% (2) 7% (2) 
BE 56.7 (2) 78% (4) 77% (4) 74% (4) 14% (4) 
SE 17.8 (3) 91% (1) 91% (2) 86% (1) 5% (1) 
PT 10.2 (4) 51% (7) 58% (7) 57% (6) 41% (7) 
FR 6.2 (5) 74% (5) 76% (5) 70% (5) 18% (5) 
UK 2.9 (6) 81% (3) 85% (3) 83% (2) 11% (3) 
IT 2.1 (7) 51% (6) 62% (6) 52% (7) 39% (6) 
Among the sample of active participants, 83% had a single membership account (variation 
from 69% for Italy to 89% for Belgium), 9% belonged to a multiple account with 2 active 
participants (from 7% for Belgium to 12% for the UK), and 8% belonged to an account with 
3 or more participants. 
Overall, 89.1% of participants never updated their intake survey (variation from 78.7% for 
Italy to 93.5% for Sweden), 8.8% updated it twice, and 2.1% updated it at least three times. 
Geographic and demographic characteristics 
All 113 NUTS2 regions of the countries analyzed were covered by the study, with an active 
participation rate per region varying between 0.3 per 100,000 (Calabria region, Italy) and 
96.1 per 100,000 (Utrecht region, The Netherlands). Geographic repartitions of Influenzanet 
participants per region were statistically different from census data (Additional file 1: Figure 
S3). Two countries – France and The Netherlands – reported a majority of regions (12 out of 
22 in France, and 8 out of 12 in The Netherlands) having a relative difference between 
Influenzanet population and national population in the range [-15%,15%) (Figure 2). Out of 
the total of 113 NUTS2 regions, 34 (30%) had a relative difference in the range [-15%,15%), 
distributed differently across countries (12 regions in France, i.e. 35.3% of the 34 regions in 
this range; 8 (23.5%) in The Netherlands; 6 (17.7%) in Italy; 5 (14.7%) in the United 
Kingdom; 2 (5.9%) in Sweden; and 1 (2.9%) in Portugal). 
Figure 2 Geographic distribution of Influenzanet participants at the level of NUTS2 
regions. The color code indicates the relative difference between the geographic distribution 
of Influenzanet population and the corresponding general population data. The map was 
created with the collected data using ArcGIS Software and publicly available geographic 
datasets [25]. 
Regarding the gender distribution in the Influenzanet population, the countries are split into 
three different sets: i) male-prevalent countries with a larger proportion of males participating 
in the project compared to the national population distribution (Belgium, Italy; p < 10-4); ii) 
female-prevalent countries (The Netherlands, United Kingdom, Sweden, and France; p < 10-
4); iii) a statistically representative population by gender (Portugal, p = 0.08) (Figure 3a). If 
we consider the aggregated data across all 7 countries Influenzanet participants are more 
likely than the general population to be female (56.8% vs. 50.9%, p < 10–4). 
Figure 3 Gender and age profiles of Influenzanet population and comparison with the 
general population. Gender repartition is displayed for each country and aggregated for all 
countries (a); age profile in 10-years classes per gender is shown aggregated for all countries 
(country level statistics are reported in Additional file 1: Figure S4) (b). 
Participants were found to be older than the general population (p = 10–3 for Italy, p < 10–5 
for all other countries), except the female participants in Portugal who were statistically 
representative of the country’s female population in terms of age (p = 0.5), and in Italy who 
were younger than the corresponding census group (p = 0.01, Table 3). Overall, there was an 
overrepresentation of the adult classes ([40-69]y) and an underrepresentation of the youngest 
classes ([0-29]y). The latter results are obtained for the entire Influenzanet population and for 
both genders (Figure 3b), and they are also valid at country level, except for France in the 
[40-49]y class (Figure 4, with no breakdown by gender). Overrepresentation of the [60-69]y 
class was confirmed by further breaking down the age group, below and above 65 years of 
age (except for the [65-69]y class in Portugal that is found to be representative of the 
corresponding age class in the general population, Additional file 1: Table S2). 
Table 3 Average age of Influenzanet participants and comparison with the national 
statistics (all p< 10–5, except *p = 0.5, †0.01 < p < 0.03, ††0.001 < p < 0.006). 
Gender Influenzanet country Influenzanet General population 
years (95% CI) years 
all BE 52.8 (52.3 – 53.3) 42.0 
FR 52.0 (51.5 – 52.5) 48.6 
IT†† 45.9 (45.0 – 46.9) 44.3 
NL 51.6 (51.3 – 51.9) 40.8 
PT 44.9 (44.0 – 45.9) 39.7 
SE 43.7 (42.8 – 44.5) 41.7 
UK 47.0 (46.2 – 47.8) 40.5 
female BE 49.0 (48.3 – 49.7) 43.3 
FR 50.8 (50.2 – 51.4) 41.2 
IT† 43.7 (42.3 - 45.2) 45.6 
NL 49.7 (49.3 – 50.0) 41.6 
PT* 42.4 (41.0 – 43.8) 41.9 
SE†† 44.3 (43.3 – 45.3) 42.9 
UK 45.5 (44.6 – 46.5) 41.5 
male BE 56.0 (55.4 – 56.7) 40.7 
FR 54.3 (53.4 – 55.2) 38.2 
IT 47.5 (46.3 – 48.8) 43.0 
NL 54.3 (53.9 – 54.8) 40.0 
PT 47.5 (46.1 – 48.9) 37.6 
SE† 42.5 (40.8 – 44.2) 40.6 
UK 49.4 (48.0 – 50.7) 39.4 
Figure 4 Age profile of Influenzanet participants and comparison with the general 
population per country. Age distribution is shown in 10-years age classes. Country profiles 
by age and gender are reported in Additional file 1: Figure S4. 
The class of young adults, from 30 to 39 years of age, showed different results depending on 
gender (Figure 3, when all countries are considered) and on the country (Figure 4 and 
Additional file 1: Figure S4). 
Gender-specific differences in the representativeness of Influenzanet participants are also 
found in the older classes. Each country reported an underrepresentation of the 70+ class 
when all participants are considered, with the male class being however overrepresented in 
the majority of countries (Belgium, France, The Netherlands and UK, Additional file 1: 
Figure S4). This gender disproportion is also confirmed if we consider all Influenzanet 
countries aggregated (Figure 3b). 
Mobility features 
Among the active participants, 55% (13,748 individuals) provided information on their 
school/work locations. The majority of participants reported commuting within the 
administrative region of their residence. The ratio between across-regions and within-regions 
commuters varied from 48% (UK) to 2.5% (Italy), and was statistically representative of the 
corresponding census ratios (Table 4, p > 0.1 for all countries). 
Table 4 Average ratio between the number of individuals commuting outside and within 
their region of residence (all p > 0.1) and comparison with national statistics 
Influenzanet country Influenzanet General population 
 Ratio between across-regions 
and within-regions commuters 
(95% CI) 
Ratio between across-regions 
and within-regions commuters 
(95% CI) 
BE 0.429 (0.021 - 1.000) 0.371 
FR 0.053 (0.000 - 0.213) 0.037 
IT 0.025 (0.000 - 0.135) 0.014 
NL 0.189 (0.102 - 0.343) 0.182 
PT 0.164 (0.000 - 0.806) 0.041 
SE 0.028 (0.0 - 0.102) 0.051 
UK 0.478 (0.0 - 2.746) 0.251 
In the census commuting network all NUTS2 regions have either in-coming or out-going 
commuting links with other regions in the country. In the Influenzanet network, only a 
portion of links were represented (Additional file 1: Table S3) with several regions remaining 
disconnected in the network, as they did not report either incoming or outgoing commuters (4 
regions in France, 3 in Italy, 2 in Portugal, 1 in Sweden and 3 in the UK). The fraction of 
represented links correlated well with the participation rate in the country (Figure 5a). 
Moreover, represented links were in general found among the ones with higher probability 
POD of occurrence (Figure 5b). 
Figure 5 Quantitative analysis of the Influenzanet commuting network. (a) Linear 
correlation between the fraction of commuting links represented in Influenzanet and the 
fraction of active participants per country (R2 =0.96). (b) Statistical analysis of the traffic 
weights of the links represented in Influenzanet. For each country, the median rank of the 
commuting links represented in the Influenzanet population (red dot) is compared with a 
random sample (grey bar). Commuting links are ranked for decreasing probability of 
occurrence POD. Median ranks are smaller than the corresponding value for the random 
sample, and outside of the confidence interval for all countries except Sweden. 
The Influenzanet commuting network was able to capture some of the relevant features of the 
census commuting patterns (Figure 6). Where a small fraction of links was represented, 
Influenzanet commuting network was still able to reproduce the strongly connected portions 
of the census commuting network in given regions (for instance, in the North of Italy, in the 
South of France, and in the South of Sweden). Commuting flows to/from central urban areas, 
like Paris and London, and the triangular pattern in the North of Portugal were also 
recognizable. Variations were observed in connections to peripheral areas, with some cases 
being reproduced (Corsica to Metropolitan France, and Northern Ireland to the rest of Great 
Britain), whereas others being absent from the Influenzanet commuting network (Madeira 
archipelago to continental Portugal, and North-South axis in Sweden). 
Figure 6 Comparison between the Influenzanet commuting network (left) and the 
backbone of the census commuting network (right). The color code associated to the links 
in the census commuting network is proportional to the adjusted weight (from yellow to dark-
red). Both networks are directed, arrows are omitted for the sake of visualization. Maps were 
created with the collected data using ArcGIS Software and publicly available geographic 
datasets [25]. 
Census backbones and Influenzanet networks showed an overlap ranging from 0.18 (Sweden) 
to 0.85 (Belgium) (Additional file 1: Table S4). The adoption of an alternative definition of 
network backbone displays a lower similarity between the two networks (Figure A5). 
The comparative analysis on the mode of transport on a regular day among participants of 15 
years or older shows that the main mode of transport was statistically representative of the 
national data for one country only (Italy, Figure 7). For all other countries, differences in the 
distributions were found to be significant (p < 10–4). 
Figure 7 Distribution of the use of transportation modes for Influenzanet participants 
and comparison with national statistics. 
Socio-economic factors 
Influenzanet participants belonged on average to larger households than the general 
population (Table 5, p < 10–3 for each country). The distributions of the number of 
household’s members of Influenzanet participants were statistically different from the 
national ones (p < 10–4, Figure 8). All countries except Italy reported a smaller proportion of 
households of size equal to 1, with the smallest value observed in Sweden (5.87% vs. 39.3%) 
and the largest one observed in Italy (32.08% vs. 30.1%). 
Table 5 Average household size of Influenzanet participants and comparison with 
national statistics (all p < 10–3) 
Influenzanet country Influenzanet General population 
household size (95% CI) household size 
BE 3.4 (3.3 – 3.5) 2.3 
FR 2.9 (2.8 – 3.0) 2.2 
IT 2.8 (2.7 – 3.0) 2.4 
NL 3.2 (3.2 – 3.3) 2.2 
PT 4.0 (3.2 – 4.8) 2.6 
SE 3.9 (3.3 – 4.5) 2.1 
UK 4.0 (3.1 – 5.0) 2.3 
Figure 8 Household size distribution for Influenzanet participants and comparison with 
national statistics. 
  
Country-specific differences were found regarding employment representativeness (Table 6). 
No significant difference was found in the UK; the employed were marginally oversampled 
in Portugal and marginally undersampled in Sweden. Larger discrepancies are found in the 
rest of the countries, with Belgium, Italy, and France overestimating the national employment 
rates, and The Netherlands showing the opposite trend. 
Table 6 Employment rate in the [15-64]y class of age and comparison with national 
statistics (all p < 10–3, except *p = 0.09, †0.01 < p < 0.05 
Influenzanet Country Influenzanet General population 
% (95% CI) % 
BE 68.6 (66.7 – 70.4) 61.9 
FR 70.9 (68.8 – 73.0) 63.8 
IT 66.2 (61.2 – 71.0) 56.9 
NL 72.6 (71.7 – 73.6) 74.9 
PT† 68.2 (64.6 – 71.5) 64.2 
SE† 71.3 (68.4 – 74.0) 74.1 
UK* 68.1 (65.4 – 70.7) 70.4 
In the three countries where education data at the general population level was available for 
comparison with Influenzanet data (France, Portugal and Sweden), participants had a higher 
education level than the general population (Table 7). 
Table 7 Education level of Influenzanet participants and comparison with national 
statistics (all p < 10–6) 
Influenzanet country: 
Indicator 
Classes Influenzanet General 
population 
% of 
individuals 
% of 
individuals 
FR: individuals with at least 
high-school level 
[25-34]y (female;male) 95.1; 96.9 70.2; 61.7 
[35-44]y (female;male) 93.6; 94.1 54.9; 47.6 
[45-54]y (female;male) 83.6; 87.1 39.4; 32.9 
[55-64]y (female;male) 81.8; 71.8 30.1; 29.9 
PT no qualification ([15-64]y; 
65+) 65+) 
0; 0 3.6; 36.2 
GCSE ([15-64]y; 65+) 3.5;10.3 60.2; 55.7 
A-level ([15-64]y; 65+) 16.3;27.0 20.6; 3.0 
higher ([15-64]y; 65+) 80.2; 62.9 15.6; 5.1 
SE: individuals in [20-64]  
age class 
no qualification (female; 
male) 
0; 0 13; 17 
GCSE (female; male) 2; 3 23; 26 
A-level (female; male) 17; 25 23; 25 
bachelor (female; male) 16;14 16; 14 
higher (female; male) 66; 57 25; 18 
Health factors and vaccination 
The prevalence of daily smokers in the 15+ age class is significantly lower in Influenzanet 
participants than in the general population across all countries (p < 10–3) except in France 
where it is statistically representative (21.51% vs. 23.3%, p = 0.08) (Figure 9). Similar results 
are obtained for the male population, whereas in the female class also Portugal and Italy, in 
addition to France, report Influenzanet smoking prevalence in agreement with national 
statistics (Additional file 1: Table S5). 
Figure 9 Prevalence of different health indicators: smoking in the 15+ population, 
asthma, diabetes, and vaccination against influenza in the 65+ population. Influenzanet 
prevalence is compared to national statistics. 
The percentage of Influenzanet participants reporting asthma is significantly lower than in the 
general population of Portugal (3.04% vs. 6.80%,p < 10–5), Italy (4.2% vs. 6.1%, p < 10–2), 
and the UK (9.2% vs. 11%, p = 0.02). The opposite trend is obtained for The Netherlands 
(8.4% vs. 3.2%, p < 10–6) and Belgium (3.95% vs. 2.8%, p < 10–4). No significant difference 
was found in France (5.9% vs. 6%, p = 0.8). Results are reported in Figure 9. 
Influenzanet diabetes prevalence was in agreement with national data for three countries (The 
Netherlands, Belgium, and France, with p = 0.8, p = 0.2, and p = 0.7, respectively), and lower 
for the others (p = 0.02 for Sweden, p = 0.01 for Portugal, p < 10–3 for Italy and UK, Figure 
9). 
Vaccination coverage against influenza in the 65+ age class during the 2011/2012 season was 
larger in the Influenzanet participants of France, Portugal and Sweden, whereas it was 
statistically representative in Italy (57.2% vs. 62.7%, p = 0.8) and UK (74.21% vs. 74%, p = 
0.98) (Figure 9). In the 2010/2011 season, vaccination coverage was higher among 
Influenzanet participants in all countries (p < 10–4), except in Italy where vaccinated 65+ 
individuals were strongly underrepresented (35% vs. 62%, p < 10–4), and in UK where 
vaccination coverage was in agreement with national data (75% vs. 73%, p =0.55, see 
Additional file 1: Table S6). Dutch data were not available for comparison for the 2011/2012 
season and Belgian data were not available for both seasons. 
Sensitivity analysis 
Repeating the analysis with a stricter inclusion criterion produced no qualitative differences 
in the results presented. 
The updates of the intake survey for 10.9% of the total number of participants most 
frequently concerned the participant’s job (place of work; occupation; main activity), her 
weight (in the French survey only, where a question on weight and height was added to 
evaluate the participant’s BMI), her mean of transport (main mean of transport; time spent 
daily on public transportation), and her place of living. These changes do not affect the 
results obtained for the representativeness in terms of age, gender, household, and health 
indicators. The changes in the geographic and job indicators produced no qualitative 
differences in the results presented. 
The representativeness analysis on the following two seasons (2012/2013 and 2013/2014) 
showed that the obtained results are robust in time (Additional file 1). No qualitative 
difference was observed, except for the Influenzanet vaccination coverage in France that was 
found to be representative of the corresponding value in the general population, differently 
from the 2011/2012 season. Differences in the participation of specific age groups were 
observed in some countries (e.g. in the UK where a higher participation of school-aged 
children was reported in the 2013/2014 season thanks to school-specific activities and 
communication campaigns), without altering the overall picture of lack of representativeness 
in terms of age observed for all participating countries. 
Discussion 
31,674 residents in 7 European countries joined the online surveillance study in the first 
season (2011/2012) where a standardized and uniform data collection approach was adopted 
by the Influenzanet Consortium. Active participation was observed for 80% of the 
participants and covered all NUTS2 regions included in the project. Participation varied 
widely across countries, geographic regions, gender groups, and age classes. This is most 
likely related to different factors, namely: the reachability of a given portion of the population 
obtained through communication campaigns; the availability, usage of and familiarity with 
the Internet (which is used in this study as the mean to collect data); and the self-selection of 
participants, or ‘volunteer effect’, and the underlying interest towards the object of the study 
[61]. 
Results seem to indicate that coverage biases due to the Internet may partly explain the 
observed variability in participation per country, however all tests were non-significant likely 
due to the small number of data points. Belgium and Portugal showed a better ranking in 
participation rates with respect to the various Internet indicators, pointing to a larger 
participation than expected based on country ranking for Internet usage only, which is likely 
due to the longer history of the national platforms (Belgium from 2003 together with The 
Netherlands, and Portugal from 2005). The Netherlands, France, and Italy ranked in 
participation approximately as expected by Internet access and usage statistics. Conversely, 
Sweden and the United Kingdom were ranked lower in participation rates (3rd and 6th, 
respectively) than according to Internet statistics. It is important to note that for France and 
Sweden it was their first season in the project. 
Geographic distribution within each country was not representative, and a larger participation 
was generally observed in those regions hosting the laboratory/Institution conducting the 
study, likely reflecting a more powerful effect of communication campaigns at the local level. 
Other initiatives, geographically limited, appear to be responsible for large participation rates 
in the population. This is for example the case of the Corsica region, with a participation rate 
of 3.5 per 100,000 vs. 2.4 per 100,000 observed in the region of the Ile de France (hosting the 
Supporting Institution), following the diffusion of localized communication campaigns and 
Influenzanet activities at schools in the region supported by a regional project [62]. 
An unbalance in the participation by gender was observed, except in the case of Portugal. 
Two opposed aspects may be at play in the gender imbalance. On one hand, previous studies 
suggest that women are on average more interested in health-related topics and also exhibit a 
more active information-seeking behavior [63,64]. Such gender-specific behavior may thus 
lead to a more likely voluntary female participation in a health-related project like 
Influenzanet, as observed in The Netherlands, UK, Sweden, and France. Results showing a 
higher tendency of participation of larger households in the study may further support this 
hypothesis, as possibly driven by women’s interest in family and children care [65]. 
On the contrary, Belgium and Italy showed a larger fraction of male participants with respect 
to the national partition by gender. This might be explained by another gender-specific 
aspect, regarding the usage of and familiarity with technology in general. Internet usage 
differs by gender across all countries, with a larger fraction of men accessing the Internet at 
least once per week compared to women [57]. Interestingly, the countries with the largest 
relative difference in the gender-specific access to the Internet (Italy, Portugal and Belgium, 
with a relative difference of 18%, 11%, and 7%, respectively) were also the countries with a 
larger prevalence of male Influenzanet participants (Belgium and Italy) or displaying a 
representative population by gender (Portugal). A larger disproportion in men’s vs. women’s 
Internet access appears therefore to balance out the female volunteering effect due to health-
interest, family care, and information-seeking behavior. 
The Influenzanet population was not representative in terms of age, with an 
overrepresentation of the [40-69]y class (for each gender), an underrepresentation of the 
younger age classes, [0-29] (for each gender), and of the elderly (age > 70y, for all countries 
when both genders are considered together). Internet usage statistics report a decreasing 
dependence on age [57], with larger (e.g. Italy and Portugal) to smaller (e.g. The Netherlands 
and Sweden) variations by age classes. This decreasing rate by age may explain the low rates 
of participation observed in the 70+. To achieve a better representativeness of individuals in 
this class, the surveillance system will need to design targeted communication campaigns for 
this group and, most importantly, facilitate the accessibility to the project. It is interesting to 
note that individuals in the [60-69] age class are largely overrepresented. We tested whether 
this may be induced by a specific interest and concern of individuals of 65+ years of age for 
whom influenza vaccination is recommended in Europe, but found no major difference in the 
representativeness of [60-64] vs. [65-69] class to support this hypothesis. 
Underrepresentation in the [0-9] and [10-19] classes of age may be due to the impossibility to 
access the Internet in an unsupervised way for the youngest children, and to the unlikelihood 
of being exposed to the project for the older ones. The system already incorporates the 
possibility of adding multiple users to an account managed by a single participant who is 
supposed to facilitate the input of data for individuals who cannot or are not familiar with 
Internet tools. The results of this study for the 2011/2012 season indicate, however, that more 
specific efforts in reaching out to younger age classes are needed, for instance through 
projects and communication/entertainment actions at schools. Such actions may be for 
example responsible for the increase in participation rates in school-aged children observed in 
the UK in the 2013/2014 season. 
A lack of interest in influenza or health-related topics may be at the basis of the 
underrepresentation of the [20-29] age class, since this is the group having the most largely 
diffused usage of new technologies, with an at least weekly Internet access reported for more 
than 88% of individuals between 16 and 34 years old for all countries studied, with the 
exception of Italy (81% for [16-24]y and 70% for [25-34]y) and Portugal (89% and 77%, 
respectively). The class of [30-39] years old instead showed a different participation behavior 
depending on the gender (overrepresentation of females and underrepresentation of males) 
and on the country (underrepresentation in Belgium, France and The Netherlands, when both 
genders are considered, opposite trend elsewhere). This age class may represent the transition 
between young-specific lack of interest for the project and the raise of family-specific interest 
for health-related information. The average age at first childbirth is indeed found between 28 
years (Belgium) and 30 years (Italy) in 2010 [66]. Other possible mechanisms may clearly 
come into play, such as e.g. a more general increased responsibility towards society and 
public good. 
Once the non-representative nature of the Influenzanet population in terms of age and gender 
was adjusted for, commuting patterns registered by Influenzanet reproduced well the ratio 
between the within-region and the across-region number of commuters, recovering a feature 
that is relevant for the spatial spread of influenza. The proportion of census links represented 
in the Influenzanet network was larger for the countries with higher number of active 
participants, showing that a better representativeness of the topology of the network can be 
reached with higher levels of participation. When only a small fraction of links was 
represented, those were in general the ones with higher census traffic, i.e. the network 
backbone. 
The analysis of transportation modes showed that the Influenzanet sample, despite being non 
representative for 6 countries out of 7, reproduced some of the aspects of the general 
population transport behavior, like the top three transportation modes, that were the same in 
the Influenzanet and in the general population for all countries except Sweden. 
Participants in general had higher education levels compared to the general population, which 
is in agreement with previous studies employing web-based surveys [67,68], and is likely 
induced by the non-representative nature of Internet users (Internet usage dramatically 
increases with education level [57]) and of the sample of individuals highly engaged in the 
survey’s topic. 
Our interpretation of partially incomplete data for the household composition (see Methods) 
offers a lower boundary for the household size, therefore it does not qualitatively alter our 
findings on larger household sizes found for Influenzanet participants. Other assumptions 
adopted for the study were tested for sensitivity (i.e. stricter inclusion criteria and 
consideration of the first intake only neglecting following updates) and no qualitative 
differences were observed in the results. 
The Influenzanet sample contained fewer smokers than expected from national statistics, with 
few exceptions (representativeness for France for both genders and for Portugal and Italy for 
the female sample only). International comparability on such statistics is however limited due 
to the lack of standardization in the measurements of smoking habits in health interview 
surveys across EU member states (see e.g. differences found across different sources, Refs. 
[54] and [21]). For example, there are variations in the wording of questions and in the 
response categories used in surveys for smoking behaviors (e.g. smoking daily vs. regularly). 
Our results consider the Influenzanet responses for daily smoking habits (i.e. less than 10, 10 
or more cigarettes per day, excluding occasional smokers) compared to the national statistics 
defined in terms of ‘daily smoking’ [54]. 
Vaccination coverage against influenza in the 65+ age class was statistically representative of 
national coverage in Italy and the UK, and it was higher in the samples of the other countries. 
Vaccination coverage reported for Italy for the previous season (participants were asked 
about their vaccination status in the previous season too) was much smaller than what has 
been declared for the season under study (the latter being also statistically representative of 
national data). No clear explanation is available, given that the sample of individuals 
declaring the vaccination status is the same. It may be due either to memory biases in the 
reporting of previous season vaccination behavior, or to change of vaccination behavior from 
one season to another. The 2010/2011 season was indeed the first influenza season following 
the 2009 H1N1 influenza pandemic, and the reported coverage may be the result of the 
negative impact of the controversies related to the pandemic vaccination campaign of 
2009/2010 on subsequent seasonal influenza vaccination coverage. While this hypothesis was 
explicitly tested in some countries where no association was found [69], we are not aware of 
similar studies being conducted in Italy, and we argue that the large variability observed in 
the attitudes towards vaccination uptake during the H1N1 pandemic [70] may possibly lead 
to different results that are country-specific. 
Overall, health-related results further indicate a tendency of Influenzanet participants towards 
better health and towards health care, with few exceptions. Furthermore, an analysis on the 
Body Mass Index of French participants have shown that they were less frequently found to 
be overweight and obese than the French population [21], further supporting such tendency. 
For sensitivity analyses we also tested the robustness of our findings for the two influenza 
seasons following the standardization of the Influenzanet platform. The only qualitative 
difference was found in the vaccination coverage of the 65+ Influenzanet population in 
France that was representative of the corresponding national value for both 2012/2013 and 
2013/2014 seasons, whereas in the 2011/2012 season a marginal overrepresentation was 
observed. It is to be noted however that some statistics for the general population for some of 
the indicators considered here were not available for all countries at the time of the study (e.g. 
vaccination coverage for the last influenza season, or asthma and diabetes incidences). Other 
differences, however not altering the findings reached for the 2011/2012 season, included an 
increase in the participation rate of school-aged children in the UK, following targeted 
communications in the country. Larger quantitative differences that may alter the conclusions 
of this study may be found on longer timeframes of data collection, induced by population 
changes in some of the indicators that may drive the participation to the surveillance scheme. 
For example, in the longitudinal study of eight seasons of the Belgian platform, Vandendijck 
and collaborators found a marked increase in participation in the [60-69] age class, likely 
attributable to the growing internet usage in this age group during that timeframe [13]. 
In addition to the self-selection bias, another potential limitation of the study is induced by 
the employed data collection methodology that may have an effect on data reliability when 
participants self-report inaccurate information. This may happen unconsciously, e.g. due to 
the fact that participants mistakenly introduce wrong data or might forget to report an 
information, or as the result of a deliberate action. In the first case, while simple mistakes in 
completing the surveys may be automatically checked by the system (as e.g. a date of birth in 
the future) or avoided with design improvements, all errors related to misunderstandings, 
subjective interpretation or memory effects in the reporting would go undetected. Studies 
have found that Web participants’ responses contained less random and systematic error than 
their telephone counterparts [71]. This was explained as an effect of the lack of social 
compliance towards the interviewer and the availability of a longer time to process the 
information at the individual’s own pace [72]. Moreover, memory effects leading to a 
systematic error known as recall bias are expected to occur when surveying participants’ 
behavior on a large set of indicators regarding events or experiences from the past. We 
evaluate that such bias is unlikely to occur in the intake survey of Influenzanet, as the 
questions asked refer to standard demographic information and everyday habits or conditions 
(e.g. smoking behavior, main mean of transportation, presence of allergies, etc.). For the 
same reason, also misunderstandings and wrong interpretations of the questions are unlikely 
to occur. 
The only question referring to a particular event in time contained in the Influenzanet intake 
survey is the one on the vaccination status. If the vaccination occurs after the completion of 
the intake survey, the participant may forget to update the information on her personal space, 
thus inducing a bias in our results. We evaluate that such cases, if present, would represent a 
small fraction of the total, as the Influenzanet surveillance campaign typically starts after the 
vaccination campaign in each of the countries. Nonetheless, a simple reminder concerning the 
update of the vaccination status can be easily implemented to overcome this issue. 
Concerning deliberate actions of providing inaccurate data on online surveys, the probability 
of filling in fraudulent data in a web-based survey, though possible, is expected to be very 
limited due to the absence of specific incentives, and the time resources needed to perform 
the fraudulent action. 
Conclusions 
The analysis of the characteristics of approximately 25,000 participants in the Influenzanet 
network of online platforms for influenza-like-illness surveillance showed a large variability 
across countries in terms of representativeness. The youngest and oldest age classes were all 
underrepresented, and gender representativeness was reached only for one country out of 
seven. Participants’ households were found to be larger than those of the general population, 
and participants’ health indicators overall indicated a higher concern for health-related issues. 
The advantage of the system is to allow the evaluation of representativeness along a large set 
of population aspects. The study indicated areas in which specific strategies and updates in 
future surveillance may be envisioned for the recruitment of undersampled groups of the 
general population. The evaluation findings will be used to correctly interpret 
epidemiological data and assess risk factors to inform public health policy. 
Competing interests 
The authors declare that they have no competing interests. 
Authors’ contributions 
PC was involved in the analysis of data and presentation of results. MD, CT, CP contributed 
to the analysis of data. All authors contributed to the setup, maintenance, design and conduct 
of the Influenzanet surveillance study during the season 2011/2012, and contributed to the 
writing of the manuscript. VC wrote the first draft of the manuscript, conceived and 
coordinated the study. All authors read and approved the final manuscript. 
Acknowledgements 
We particularly thank all European participants who took part in the Influenzanet project in 
the 2011/2012 season. We also thank Niel Hens for useful discussions and for sharing 
Flemish general population health data, and Patricia Soares for help extracting the Portuguese 
general population data. This work is partly supported by the U707/InVS partnership contract 
n°12-N-MIP20-04, and the ANR contract no. ANR-12-MONU-0018 (HARMSFLU). 
References 
1. World Health Organization: Global Influenza Surveillance and Response System 
(GISRS). http://www.who.int/influenza/gisrs_laboratory/en/. 
2. OECD: Participative Web and User-Created Content. Web 2.0, Wikis and Social 
Networking. OECD Publishing; 2007. 
3. Marquet RL, Bartelds AIM, van Noort SP, Koppeschaar CE, Paget J, Shellevis SG, van der 
Zee J: Internet-based monitoring of influenza-like illness (ILI) in the general population 
of the Netherlands during the 2003-2004 influenza season. BMC Public Health 2006, 
6:e242. 
4. Influenzanet. http://www.influenzanet.eu/. 
5. Paolotti D, Carnahan A, Colizza V, Eames K, Edmunds J, Gomes G, Koppeschaar C, Rehn 
M, Smallenburg R, Turbelin C, Van Noort S, Vespignani A: Web-based participatory 
surveillance of infectious diseases: the Influenzanet participatory surveillance 
experience. Clin Microbiol Infect 2014, 20:17–21. 
6. Centers for Disease Control and Prevention: Updated guidelines for evaluating public 
health surveillance systems. Recommendations from the Guidelines Working Group. 
MMWR 2001, 50(RR–13):1–35. 
7. Ginsberg J, Mohebbi MH, Patel RS, Brammer L, Smolinski MS, Brilliant L: Detecting 
influenza epidemics using search engine query data. Nature 2009, 457:1012–1014. 
8. Pelat C, Turbelin C, Bar-Hen A, Flahault A, Valleron AJ: More diseases tracked by 
using Google Trends. Emerg Infect Dis 2009, 15:1327–1328. 
9. Brownstein JS, Freifeld CC, Reis BY, Mandl KD: Surveillance Sans Frontieres: 
internet-based emerging infectious disease intelligence and the HealthMap project. 
PLoS Med 2008, 5:e151. 
10. Brownstein JS, Freifeld CC, Madoff LC: Digital disease detection–harnessing the Web 
for public health surveillance. N Engl J Med 2009, 360:2153–2157. 
11. Signorini A, Segre AM, Polgreen PM: The use of Twitter to track levels of disease 
activity and public concern in the U.S. during the influenza A H1N1 pandemic. PLoS 
One 2011, 6:e19467. 
12. deGroteGriepMeting. https://www.degrotegriepmeting.nl/. 
13. Vandendijck Y, Faes C, Hens N: Eight years of the great influenza survey to monitor 
influenza-like illness in Flanders. PLoS One 2013, 8(5):e64156. 
14. gripenet. http://www.gripenet.pt/. 
15. van Noort SP, Muehlen M, Rebelo de Andrade H, Koppeschaar C, Lima Lourenco JM, 
Gomes MG: Gripenet: an internet-based system to monitor influenza-like illness 
uniformly across Europe. Euro Surveill 2007, 12:229–233. 
16. Influweb. https://www.influweb.it/. 
17. Tilston NL, Eames KTD, Paolotti D, Ealden T, Edmunds WJ: Internet-based 
surveillance of Influenza-like-illness in the UK during the 2009 H1N1 influenza 
pandemic. BMC Public Health 2010, 10:e650. 
18. Flusurvey. http://flusurvey.org.uk/. 
19. influensakoll. https://www.influensakoll.se/. 
20. GrippeNet.fr. http://www.grippenet.fr/. 
21. Debin M, Turbelin C, Blanchon T, Bonmarin I, Falchi A, Hanslik T, Levy-Bruhl D, 
Poletto C, Colizza V: Evaluating the representativeness of an online nationwide 
surveillance system for influenza in France. PLoS One 2013, 8(9):e73675. 
22. InVS, Institut de veille sanitaire. http://www.invs.sante.fr/. 
23. Réseau Sentinelles Bulletin hebdomadaire. http://websenti.u707.jussieu.fr/sentiweb/. 
24. Friesema IHM, Koppeschaar CE, Donker GA, Dijkstra F, van Noort SP, Smallenburg R, 
van der Hoek W, van der Sande MA: Internet-based monitoring of influenza-like illness in 
the general population: experience of five influenza seasons in the Netherlands. Vaccine 
2009, 27:6353–6357. 
25. Eurostat, European Commission. http://epp.eurostat.ec.europa.eu/portal/page/portal/ 
eurostat/home. 
26. NUTS, Nomenclature of Territorial Units for Statistics. http://epp.eurostat.ec. 
europa.eu/portal/page/portal/nuts_nomenclature/introduction. 
27. Eurostat: Distribution of households by household size. http://appsso.eurostat.ec. 
europa.eu/nui/show.do?dataset=ilc_lvph03&lang=en. 
28. Eurostat: Average household size. http://appsso.eurostat.ec.europa.eu/nui/show.do? 
dataset=ilc_lvph01&lang=en. 
29. Institut national de la statistique et des études économiques: Les estimations de 
population. http://www.insee.fr/fr/publications-et-services/default.asp?page=dossiers_web/ 
population/estimations_pop.htm#p2. 
  
30. Pordata, Base de dados Portugal contemporaneo: Resident population aged 15 to 64 
and 65 and over: by highest level of educational qualifications obtained. 
http://www.pordata.pt/en/Portugal/Resident+population+aged+15+to+64+and+65+and+over
+by+highest+level+of+educational+qualifications+obtained+%28percentage%29-2266. 
31. Statistics Sweden: Educational attainment and employment of the population 2010. 
http://www.scb.se/Pages/PublishingCalendarViewInfo____259924.aspx?PublObjId=17126. 
32. OECD: “Employment rate”, Employment and Labour Markets: Key Tables from OECD, 
No. 4. doi: 10.1787/emp-table 2012-1-en. 
33. European Commission: Future of transport. analytical report. 2011. 
http://ec.europa.eu/public_opinion/flash/fl_312_en.pdf. 
34. Caisse Nationale d’Assurance Maladie, Ministère des affaires sociales et de la santé, 
Agence nationale de sécurité du médicament et des produits de santé, Institut de veille 
sanitaire: Campagne de vaccination contre la grippe saisonnière 2012-2013. 
http://www.sante.gouv.fr/IMG/pdf/dossier_presse_grippe_2012_28092012.pdf. 
35. Institut national de la statistique et des études économiques: Les variables issues de la 
Caisse Nationale d’Assurance Maladie des Travailleurs Salariés (CNAMTS). 
http://www.insee.fr/fr/ppp/bases-de-donnees/donnees-
detaillees/duicq/accueil.asp?page=doc/cnam.htm. 
36. Tuppin P, Choukroun S, Samson S, Weill A, Ricordeau P, Allemand H: Vaccination 
against seasonal influenza in France in 2010 and 2011: decrease of coverage rates and 
associated factors. Presse Med 2012, 41:568–576. 
37. Dutch National Public Health Compass: Influenza. http://www.nationaalkompas.nl/ 
preventie/van-ziekten-en-aandoeningen/influenza/bereik/. 
38. Nunes B, Branco MJ: Vacinação antigripal da população portuguesa, em 2011-2012: 
cobertura e algumas características do acto vacinal. Lisboa: Instituto Nacional de Saúde Dr. 
Ricardo Jorge. Departamento de Epidemiologia, Documento interno. http://repositorio. 
insa.pt/handle/10400.18/1010. 
39. Italian Ministry of Health: Coperture vaccinali medie per regione. 
http://www.salute.gov.it/influenza/paginaInternaMenuInfluenza.jsp?id=679&menu=strumenti
eservizi. 
40. UK Health Protection Agency: Weekly Report 31st March 2011. 
http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1296684494218. 
41. UK Health Protection Agency: Weekly Report 22nd March 2012. 
http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317133280485. 
42. Ecosante. http://www.ecosante.fr. 
43. Dutch National Public Health Compass: Diabetes. http://www.nationaalkompas.nl/ 
gezondheid-en-ziekte/ziekten-en-aandoeningen/endocriene-voedings-en-
stofwisselingsziekten-en-immuniteitsstoornissen/diabetes-mellitus/omvang/. 
44. Belgian health interview survey 2008. https://his.wiv-isp.be/SitePages/Home.aspx. 
45. Portuguese National Institute of Health: Relatório Anual da Diabetes. 
http://www.insa.pt/sites/INSA/Portugues/ComInf/Noticias/Paginas/RelatorioAnualDiabetes.a
spx. 
46. Italian National Institute of Health: La patologia diabetica: dati di prevalenza a livello 
nazionale. http://www.epicentro.iss.it/igea/PrimoPiano/prevalenza.asp. 
47. Diabetes UK: Reports and statistics. diabetes prevalence 2011. 
http://www.diabetes.org.uk/Professionals-old/Publications-reports-and-resources/Reports-
statistics-and-case-studies/Reports/Diabetes-prevalence-2011-Oct-20111/. 
48. Diabetes Sweden: Reports and statistics. http://www.diabetes.se. 
49. Dutch National Public Health Compass: Asthma. http://www.nationaalkompas.nl/ 
gezondheid-en-ziekte/ziekten-en-aandoeningen/ademhalingswegen/astma/omvang/. 
50. Sa-Sousa A, Morais-Almeida M, Azevedo LF, Carvalho R, Jacinto T, Todo-Bom A, 
Loureiro C, Bugalho-Almeida A, Bousquet J, Fonseca JA: Prevalence of asthma in 
Portugal - the Portuguese National Asthma Survey. Clin Transl Allergy 2012, 2(1):15. 
51. Italian National Institute of Health: Persone con presenza di alcune malattie croniche. 
http://dati.istat.it/Index.aspx?DataSetCode=DCCV_MALCRON. 
52. Simpson CR, Sheikh A: Trends in the epidemiology of asthma in England: a national 
study of 333,294 patients. J R Soc Med 2010, 103(3):98–106. 
53. Swedish Heart-Lung Foundation: Research on Asthma. http://www.hjart-lungfonden.se/ 
Forskning/Aktuell-forskning/Lungforskning/Forskning-om-astma/. 
54. OECD, health at a glance: Europe 2012. determinants of health. smoking among 
adults. http://www.oecd-ilibrary.org/sites/9789264183896-en/02/05/index.html?contentType 
=&itemId=/content/chapter/9789264183896-24-en&containerItemId=/content/serial/23056 
088&accessItemIds=/content/book/9789264183. 
55. Eschwege E, Charles M-A, Basdevant A, Moisan C, Bonnélye G, Touboule C, 
Goulhamousen N, Crine A: ObEpi Roche 2012 - Enquête épidémiologique nationale sur 
le surpoids et l’obésité. http://www.roche.fr/content/dam/corporate/roche_fr/doc/obepi 
_2012.pdf. 
56. Balcan D, Colizza V, Goncalves B, Hu H, Ramasco JJ, Vespignani A: Multiscale 
mobility networks and the spatial spreading of infectious diseases. Proc Natl Acad Sci U 
S A 2009, 106:21484–21489. 
57. Eurostat: Information society statistics. http://epp.eurostat.ec.europa.eu/statistics_ 
explained/index.php/Information_society_statistics. 
58. Barabasi AL, Albert R: Emergence of scaling in random networks. Science 1999, 
286:509–512. 
59. Barrat A, Barthelemy M, Vespignani A: Dynamical Processes on Complex Networks. 
Cambridge: University Press; 2008. 
60. Serrano MA, Boguna M, Vespignani A: Extracting the multiscale backbone of 
complex weighted networks. Proc Natl Acad Sci U S A 2009, 106:6483–6488. 
61. Friedman C, Wyatt J, Smith A, Kaplan B: Evaluation Methods in Medical Informatics. 
New York: Springer; 1997. 
62. GrippeNet.fr in Corsica. https://grippenet.fr/fr/grippenet-en-corse/. 
63. Centre de Recherche pour l’Etude et l’Observation des Conditions de Vie: Les 
opinions des femmes et des hommes sont-elles semblables ou différentes ? Cahier de 
recherche, 195. http://www.credoc.fr/pdf/Rech/C195.pdf. 
64. Fox S, Rainie L: The online health care revolution: how the web helps Americans 
take better care of themselves. http://www.pewinternet.org/~/media/Files/Reports/2000/ 
PIP_Health_Report.pdf.pdf. 
65. Crespi I, Miller T: Family, Care and Work in Europe: An Issue of Gender?. Italy: Eum, 
Edizioni Università di Macerata; 2013. 
66. UNECE (United Nations Economic Commission for Europe) Statistical Database. 
http://w3.unece.org/. 
67. Couper MP: Web surveys: a review of issues and approaches. Publ Opin Q 2000, 
64:464–494. 
68. Gosling SD, Vazire S, Srivastava S, John OP: Should we trust web-based studies? a 
comparative analysis of six preconceptions about internet questionnaires. Am Psychol 
2004, 59(2):93–104. 
69. Guthmann J-P, Fonteneau L, Bonmarin I, Levy-Bruhl D: Influenza vaccination 
coverage one year after the A(H1N1) influenza pandemic, France, 2010-2011. Vaccine 
2012, 30:995–997. 
70. Tizzoni M, Bajardi P, Poletto C, Ramasco JJ, Balcan D, Goncalves B, Perra N, Colizza 
V, Vespignani A: Real-time numerical forecast of global epidemic spreading: case study 
of 2009 A/H1N1 pdm. BMC Med 2012, 10:165. 
71. Krosnick J, Chang L: A Comparison of Random Digit Dialing Telephone Survey 
Methodology with Internet Survey Methodology as Implemented by Knowledge Networks and 
Harris Interactive, The American Association for Public Opinion Research (AAPOR) 56th 
Annual Conference. Montreal, Quebec, Canada; 2001. 
72. Dillman DA, Phelps G, Tortora R, Swift K, Kohrell J, Berck J, Messer BL: Response 
rate and measurement differences in mixed-mode surveys using mail, telephone, 
interactive voice response (IVR) and the Internet. Soc Sci Res 2009, 38:1–18. 
Additional files 
Additional_file_1 as PDF 
Additional file 1. The file contains additional information on the Influenzanet system, the 
methods used in the analysis, and additional results. 
Additional_file_2 as PDF 
Additional file 2. The file contains the Influenzanet intake survey in its English version. 
Figure 1
relative difference of geographic
distribution per NUTS2 region, 
Influenzanet vs. general population
(-100%, -30%)
[-30%, -15%)
[-15%, 15%)
[15%, 30%)
>30%
Figure 2
54%
49%
35%
48%
58%
49%
42%
49%
50%
48%
34%
50%
39%
49%
influenzanet
general pop
NL
BE
FR
UK
SE
IT
PT
43%
49%
all
countries
0−9 10−19 20−29 30−39 40−49 50−59 60−69 70+
0
5
10
15
20
25
30 female
age
%
 o
f i
nd
ivi
du
al
s
%
 o
f i
nd
ivi
du
al
s
0−9 10−19 20−29 30−39 40−49 50−59 60−69 70+
0
5
10
15
20
25
30 male
age
influenzanet
general population
(a) (b)
Figure 3
0−9 10−19 20−29 30−39 40−49 50−59 60−69 70+
0
5
10
15
20
25
30
age
age
%
 o
f i
nd
ivi
du
al
s
0−9 10−19 20−29 30−39 40−49 50−59 60−69 70+
0
5
10
15
20
25
30
0−9 10−19 20−29 30−39 40−49 50−59 60−69 70+
0
5
10
15
20
25
30
0−9 10−19 20−29 30−39 40−49 50−59 60−69 70+
0
5
10
15
20
25
30
0−9 10−19 20−29 30−39 40−49 50−59 60−69 70+
0
5
10
15
20
25
30
18−19 20−29 30−39 40−49 50−59 60−69 70+
0
5
10
15
20
25
30
0−9 10−19 20−29 30−39 40−49 50−59 60−69 70+
0
5
10
15
20
25
30
%
 o
f i
nd
ivi
du
al
s
%
 o
f i
nd
ivi
du
al
s
%
 o
f i
nd
ivi
du
al
s
influenzanet
general population
NL
BE FR
UK
SE
IT
PT
Figure 4
0 20 40 60 80
fraction of represented links (%)
0
20
40
60
80
n
o
. 
a
ct
iv
e 
pa
rti
cip
an
ts
 (p
er 
10
0,0
00
)
(a)
BE IT UK NL SE PT FR
0
20
40
60
80
100
m
e
di
an
 ra
nk
200
400
600
800
random sample
Influenzanet
(b)
Figure 5
Influenzanet commuting network backbone of the census commuting network
100
0.1
10
1
adjusted weight
Figure 6
main mode of transport
%
 o
f i
nd
ivi
du
al
s
influenzanet
general population
0
10
20
30
40
50
60
70
%
 o
f i
nd
ivi
du
al
s
0
10
20
30
40
50
60
70
%
 o
f i
nd
ivi
du
al
s
0
10
20
30
40
50
60
70
%
 o
f i
nd
ivi
du
al
s
0
10
20
30
40
50
60
70
0
10
20
30
40
50
60
70
0
10
20
30
40
50
60
70
0
10
20
30
40
50
60
70
1 2 3 4 5 6 1 2 3 4 5 6
1 2 3 4 5 6 1 2 3 4 5 6
1 2 3 4 5 6 1 2 3 4 5 6
1 2 3 4 5 6
main mode of transport
1
2
3
4
5
6
walk
bike
other
public transport
car
motorbike
NL
BE FR
UK
SE
IT
PT
Figure 7
0 % 20 % 40 % 60% 80 % 100 %
NL
BE
FR
UK
SE
IT
PT
influenzanet
general pop
1 2 3 4 5 6+
% of individualsFigure 8
NL
BE
FR
UK
SE
IT
PT
FR
UK
SE
IT
PT
VACCINATION (65+), 2011/2012
0% 20% 40% 60% 80% 100%0% 2% 4% 6% 8% 10% 12%
ASTHMA DIABETES
0% 2% 4% 6% 8% 10%0% 5% 10% 15% 20% 25%
SMOKING (15+)
NL
BE
FR
UK
SE
IT
PT
influenzanet
general populationFigure 9
Additional files provided with this submission:
Additional file 1: 1883636125125946_add1.pdf, 1778K
http://www.biomedcentral.com/imedia/5255211331433565/supp1.pdf
Additional file 2: 1883636125125946_add2.pdf, 157K
http://www.biomedcentral.com/imedia/1375515701433565/supp2.pdf
